Huzhou Sunflower Pharmaceutical

Huzhou Sunflower Pharmaceutical Co. Ltd., known as S-Pharma, was established in 2015 as a result of the pharmaceutical department spin-off from Hangzhou Sunflower Technology Development Co. Ltd. (STD). S-Pharma has inherited all of STD's assets, including facilities, technology, products, team, management, and trademarks. The company's primary focus is on the development and production of pharmaceutical excipients and API's. Under the leadership of Mr. Wu Jiaxiang, a prominent PVP founder in China, the team at S-Pharma possesses extensive process and application techniques, with 35 years of experience in sustainable R&D, engineering practice, and marketing, especially in the Polyvinylpyrrolidone series (Povidone, Crosspovidone, Copovidone, and Povidone Iodinated). S-Pharma is renowned for its comprehensive range, high quality, and excellent service within the industry, and enjoys widespread acclaim from customers both domestically and internationally. The company operates GMP production lines with capacities of 600 tons annually for Povidone at low molecular weight (Povidone K12, K15, K17, K25, and K30), 800 tons annually for Povidone at high molecular weight (Povidone K60, K90, K120), and 300 tons annually for Povidone Iodine. S-Pharma's business philosophy is centered on

Sites

Huzhou Sunflower Pharmaceutical Co., Ltd.

Country

People's Republic of China

City

Huzhou

Address

692 North Zhiyuan Road, Wukang Town

GMP Non-Compliance Report

Report Number: 15MPP013

Inspection date: 30 Jan 2015

Issue date: 25 Mar 2015